[Orbital extension of sinus plasmacytoma secondarily transforming into multiple myeloma: a case study].
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D003520:Cyclophosphamide / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004172:Diplopia / Q000209:etiology; D004317:Doxorubicin / Q000627:therapeutic use; D005005:Ethmoid Sinus / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery; D005047:Etoposide / Q000627:therapeutic use; D005094:Exophthalmos / Q000209:etiology; D006801:Humans; D008297:Male; D008443:Maxillary Sinus / Q000473:pathology; D008444:Maxillary Sinus Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000175:diagnosis*; D009915:Orbit / Q000473:pathology; D009918:Orbital Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D010255:Paranasal Sinus Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D010954:Plasmacytoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use; D014792:Visual Acuity
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D008776:Methylprednisolone Hemisuccinate; D014750:Vincristine; D005047:Etoposide; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide
Extension orbitaire d'un plasmocytome sinusien secondairement transformé en myélome multiple. A propos d'un cas.